Glycan structures on enterocyte membrane glycoproteins and glycolipids

Glycan receptors on enterocytes refer to carbohydrate-rich moieties present on membrane glycoproteins and glycolipids of intestinal epithelial cells. These surface glycans act as critical attachment sites for microbial pathogens (such as bacterial toxins), endogenous lectins (e.g., galectin-1), and other molecules, modulating processes like infection susceptibility, immune response, cell death, and intestinal homeostasis[4][3][6]. Their structure and abundance are tightly regulated by cellular glycosyltransferases, and their alteration is associated with disease states including infection, inflammation, and malignant transformation[2][7]. The term is not a single molecule but represents a complex and heterogeneous set of carbohydrate epitopes serving as functional receptors or ligands for diverse biological interactions. **Note:** For robust data structuring or pharmacological targeting, use more specific glycoprotein/lipid names (e.g., CEACAM5, specific O/N-glycan structures) rather than the general term "glycan receptors on enterocytes"[4].

Other names

Intestinal glycan receptorsEnterocyte glycan-binding sitesCell-surface glycosylation motifs (on enterocytes)Surface glyco-epitopes (on enterocytes)Fucosylated glycoproteins (subset)

Ligand binding via specific glycan recognition motifs leads to internalization or cell signaling: - Toxin binding (e.g., cholera toxin B subunit binds fucosylated glycans, mediating endocytosis and intoxication) - Lectin-induced apoptosis or cellular responses (e.g., galectin-1 induces apoptosis by binding glyco-epitopes) - Modulation of immune response through glycan-mediated recognition events